India - Haryana Covid-19 Sero Survey Round 2, October 2020 Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round) Cross-sectional - Epi surveillance - Urban-rural representative GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4 GHDx Entry last modified on: Jun 26, 2023
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1 ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase Individual - Interview GHDx Entry last modified on: Oct 21, 2022
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey Cross-sectional - Epi surveillance - Individual GHDx Entry last modified on: May 12, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19 Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: May 12, 2022
Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020 Health facility - Individual - Interview - Longitudinal GHDx Entry last modified on: Apr 10, 2023
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: Aug 1, 2022
Mexico - Yucatán Under-5 Endline Household Survey 2020 Cross-sectional - Household - Individual - Interview GHDx Entry last modified on: Mar 12, 2022
About 10 million people have been infected with the Corona virus in Afghanistan حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند GHDx Entry last modified on: Jul 13, 2021
Press Briefing: Sero Survey Delhi Cross-sectional - Urban only GHDx Entry last modified on: Feb 10, 2022
India - Haryana Covid -19 Sero Survey Round 1, August 2020 Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study Epi surveillance GHDx Entry last modified on: May 12, 2022
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey Urban only GHDx Entry last modified on: Apr 8, 2022
[Preliminary results of the National Health and Nutrition Survey COVID-19] Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19 Cross-sectional - Epi surveillance - Household - Individual - Nationally representative GHDx Entry last modified on: May 12, 2022
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020 HAARVI Health facility - Longitudinal - Outpatient GHDx Entry last modified on: Apr 10, 2023
Switzerland - Zurich COVID-19 Hospitalizations, Symptoms, Complications, Quality of Life, and Mental Wellbeing 2020-2021 Individual - Longitudinal GHDx Entry last modified on: Apr 10, 2023
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey GHDx Entry last modified on: Aug 1, 2022
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Premise General Population COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Assam’s First Sero-survey Gets Underway, Here’s Everything You Need To Know About It GHDx Entry last modified on: Aug 1, 2022
Premise Child Health COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
ORB General Population COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual - Nationally representative GHDx Entry last modified on: Dec 12, 2022
Premise Infant and Maternal Health COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Premise Women’s Health COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Premise Malaria COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Oman COVID-19 National Serological Survey Phase 1 2020 National Sero-Survey of COVID-19 Infection First Phase Cross-sectional - Epi surveillance GHDx Entry last modified on: Feb 10, 2022
Ipsos General Population COVID-19 Health Services Disruption Survey 2020 Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
COVID-19 Beliefs, Behaviors & Norms Survey 2020-2021 COVID-19 Preventive Health Survey 2020-2021 - Facebook Data for Good Cross-sectional - Individual GHDx Entry last modified on: Dec 27, 2023
United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020 Prevalence of Current and Past COVID-19 in Ohio Adults Epi surveillance - Individual GHDx Entry last modified on: May 12, 2022
Epidemiological and Serological Surveillance of COVID-19 in Pune City, Technical Report, August 16, 2020 Technical Report (dt August 16, 2020): Epidemiological and Serological Surveillance of COVID-19 in Pune City Epi surveillance GHDx Entry last modified on: Jul 26, 2021
Norway SARS-CoV-2 Seroprevalence Residual Sera Follow-up Survey July-September 2020 Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in late summer 2020 Epi surveillance - Individual GHDx Entry last modified on: May 12, 2022
CDC COVID Data Tracker Nationwide Blood Donor Seroprevalence Survey 2021-2022 Epi surveillance - Subnationally representative GHDx Entry last modified on: Jul 21, 2022
Ireland Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI) 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022
[Minsa publishes technical data of the study that reveals that 25.3% of Lima and Callao acquired COVID-19] Minsa divulga ficha técnica del estudio que revela que el 25.3% de Lima y Callao adquirió el COVID-19 Epi surveillance GHDx Entry last modified on: Jul 27, 2021
Covid antibodies found in 97% of Delhi residents Epi surveillance GHDx Entry last modified on: May 12, 2022
United States Kaiser Family Foundation Health Tracking Poll - June 2020 KFF Health Tracking Poll - June 2020 Individual - Nationally representative GHDx Entry last modified on: Jan 14, 2022
Afghanistan National COVID-19 Prevalence and Related Deaths Survey 2020 National Survey of Prevalence of COVID-19 and its Related Deaths in Afghanistan Cross-sectional - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative GHDx Entry last modified on: Oct 21, 2022
United Kingdom - Coronavirus and depression in adults, Great Britain: July to August 2021 Coronavirus and depression in adults, Great Britain: July to August 2021, Opinions and Lifestyle Survey (COVID-19 module), 2020 to 2021 Individual - Interview - Longitudinal GHDx Entry last modified on: Jul 5, 2023
One in Three Exposed to Covid Virus, Reveals Second Chennai Sero Survey GHDx Entry last modified on: May 12, 2022
Global Survey of Potential Acceptance of a COVID-19 Vaccine 2020 GHDx Entry last modified on: Sep 22, 2021
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 2 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 2 Cross-sectional - Epi surveillance - Household - Individual GHDx Entry last modified on: Jun 26, 2023
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020 Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020 Community - Cross-sectional - Exam - Urban only GHDx Entry last modified on: Aug 6, 2021
Italy SARS-CoV-2 Seroprevalence Survey, First Results 2020 Primi Risultati dell’Indigine di Sieroprevalenza sul SARS-CoV-2 Epi surveillance GHDx Entry last modified on: Sep 8, 2022
In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2 Longitudinal GHDx Entry last modified on: Feb 10, 2022
United Kingdom Coronavirus (COVID-19) Infection Survey Pilot Statistical Bulletins 2020 Coronavirus (COVID-19) Infection Survey, UK Statistical bulletins GHDx Entry last modified on: Aug 10, 2023
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2020 - Round 1 GHDx Entry last modified on: Aug 4, 2023
United States Kaiser Family Foundation Health Tracking Poll - May 2020 KFF Health Tracking Poll - May 2020 Individual - Nationally representative GHDx Entry last modified on: Jan 14, 2022
Portugal National Serological Survey COVID-19 Preliminary results 2020 Relatório de Apresentação dos Resultados Preliminares do Primeiro Inquérito Serológico Nacional COVID-19 GHDx Entry last modified on: May 12, 2022